Author name: Claritas Rx

In the rapidly evolving landscape of healthcare, patient adherence to treatment plans remains a critical challenge. For patient access teams, predicting which patients are at risk of dropping off their treatment regimens can be the difference between successful outcomes and unmet medical needs. Enter AI predictive analytics—a game changer for enhancing treatment adherence and transforming […]

Launching a pharmaceutical product can resemble navigating a labyrinth. For market access teams, the stakes are high. Implementing a successful launch strategy requires not just innovation but also strategic precision. This is where benchmarking steps in. By comparing your product’s potential performance against industry standards and competitors, you gain invaluable insights. This blog will walk

Gene therapy holds the promise to revolutionize medicine, particularly for patients with rare and genetic disorders. But how do patient access teams measure success in this complex and emerging field? Key Performance Indicators (KPIs) are essential tools that can guide you through the intricacies of gene therapy treatment, ensuring beneficial outcomes for patients and operational

The Challenge of Medication Non-Adherence in Specialty Pharmacy Medication adherence refers to whether patients take their medications as prescribed, including the correct dose, at the correct times, and for the prescribed duration. It is a crucial aspect of managing chronic conditions and maintaining overall health. Despite its importance, medication non-adherence is a significant issue. It

Introduction In the fast-paced world of biopharma, partnerships can drive remarkable advancements. GlaxoSmithKline (GSK), a global healthcare leader, is taking a bold step by teaming up with Flagship Pioneering, a trailblazer in venture creation and life sciences innovation. This collaboration aims to develop up to 10 new vaccines and pharmaceuticals, initially focusing on the respiratory

Introduction In the tough terrain of finding an Alzheimer’s cure, Eli Lilly is setting the pace with their latest innovation – the FDA-approved drug, Donanemab, commercially known as Kisunla. This blog delves into Lilly’s strategic maneuvers to expedite sales and cultivate urgent demand within the pharmaceutical sector. The vast population of patients combined with a

Within a sector populated by many market pioneers promoting injectable solutions, Pfizer is redefining the landscape with an oral medication for obesity. This article explores Pfizer‘s strategic moves towards securing a prominent position in the obesity treatment market, focusing especially on their groundbreaking work on a GLP-1 drug. Introduction Pfizer, a titan in the pharmaceutical

In the biopharma industry, understanding how your therapy basket’s fill rate stacks up against competitors can be a game-changer. This blog post dives deep into the significance of therapy basket fill rates, providing exclusive data insights and practical tips to help biopharma executives stay ahead in the competitive landscape. The Importance of Therapy Basket Fill

Picture a future in which we don’t merely manage symptoms but eliminate diseases at their roots. This future isn’t a far-off dream; it’s the promise of cell therapy. This innovative approach is currently changing the way we confront some of the toughest medical conditions. For biopharma investors, this arena doesn’t only symbolize a leap in